PNAS, 7 July 1998
Anandamide was the first brain metabolite shown to act as a ligand of “central” CB1 cannabinoid receptors. Here we report that the endogenous cannabinoid potently and selectively inhibits the proliferation of human breast cancer cells in vitro. Anandamide dose-dependently inhi…
Archive for year: 1998
https://www.cannabisclinicians.org/wp-content/uploads/2020/06/scc_logo-long-R-2-1.png 0 0 Sarah Russo https://www.cannabisclinicians.org/wp-content/uploads/2020/06/scc_logo-long-R-2-1.png Sarah Russo1998-07-07 09:19:162020-03-24 07:57:32The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.